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Abstract 
The aim of the present work is to develop simple, precise and economic UV- spectrophotometric methods for the 
simultaneous estimation of aspirin and omeprazole laboratory sample. The absorbance maxima (λmax) for detection of aspirin 
and omeprazole were selected as 274 nm and 302 nm respectively for simultaneous equation method while wavelength range 
for detection of aspirin and omeprazole were selected as 270 nm - 276 nm and 300 nm - 305 nm respectively for area under 
curve method. Absorbance ratio method uses the ratio of absorbances at two selected wavelengths, one which is an 
isoabsorptive point and other being the λmax of one of the two components. From the overlay spectra of two drugs, it is evident 
that aspirin and omeprazole show an isoabsorptive point at 238.6 nm. Zero crossing first derivative spectrophotometry, where 
Aspirin showed zero crossing point at 301nm and Omeprazole showed zero crossing point at 274nm. Linearity for Aspirin was 
between 25- 125 μg/mL and Omeprazole was 3-15 μg/mL. These methods were successfully applied for estimation of Aspirin 
and Omeprazole in laboratory sample. 
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1. Introduction  
Chemically, Aspirin is 2-(acetyloxy) benzoic acid 
which is one of the widely used non- steroidal anti-
inflammatory category drug. Aspirin is official in Indian 
Pharmacopeia, British Pharmacopoeia and United States 
Pharmacopoeia which describe acid-base titration for aspirin, 
Omeprazole (OME) is chemically (RS)-5-Methoxy-2-[[(4-
methoxy-3,5-dimethyl-2- pyridinyl)methyl] sulfinyl]-1H-
benzimidazoleis a antiulcerative (proton pump inhibitor) acts 
by suppressing gastric acid secretion by specific inhibition of 
the proton pump (H+/K+- ATPase pump) in the gastric 
parietal cell. It also inhibits gastric mucosal carbonic 
anhydrase. It is used to treat pepticulcer. It is official in 
United State Pharmacopeia. YOSPRALA is a combination of 
aspirin, an anti-platelet agent, and omeprazole, a proton pump 
inhibitor (PPI), indicated for patients who require aspirin for 
secondary prevention of cardiovascular and cerebrovascular 
events and who are at risk of developing aspirin associated 
gastric ulcers. The aspirin component of YOSPRALA is 
indicated for: 
 Reducing the combined risk of death and nonfatal stroke 
in patients who have ischemic stroke or transient 
ischemia of the brain due to fibrin platelet emboli, 
 Reducing the combined risk of death and nonfatal in 
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patients unstable angina pectoris, 
 Reducing the combined risk of MI and sudden death in 
patients with chronic stable angina pectoris, 
 Use in patients who have undergone revascularization 
procedures (Coronary Artery Bypass Graft [CABG] or 
Percutaneous Transluminal Coronary Angioplasty 
[PTCA]) when there is a pre-existing condition for which 
aspirin is already indicated. 
 
 
Fig.1 Structure of Aspirin 
 
 
 
Figure 2: Structure of Omeprazole 
 
The omeprazole component of YOSPRALA is 
indicated for decreasing the risk of developing aspirin 
associated gastric ulcers in patients at risk for developing 
aspirin-associated gastric ulcers due to age (≥ 55) or 
documented history of gastric ulcers. 
However to best of our knowledge, there is no 
reported UV-spectrophotometric method available for 
simultaneous estimation of Aspirin and Omeprazole. The aim 
of the present work was to develop four simple, rapid, 
inexpensive, precise and accurate UV spectrophotometric 
methods for simultaneous estimation of Aspirin and 
Omeprazole. 
 
2. Materials and Methods 
JascoV-730 double beam spectrophotometer 
connected to a computer loaded with Spectramanager 
software was used for all the spectrophotometric 
measurements. The absorbance spectra of the reference and 
test solutions were carried out in 1cm quartz cells over the 
range of 200-600 nm. The samples were weighed on 
electronic analytical balance (Digital weighing balance 
Shimadzu). 
2.1 Materials:  
 Gift samples of standards Aspirin and Omeprazole 
were provided Pell Tech Health Care Pvt. Ltd, Mumbai. 
2.2 Reagents and chemicals 
All chemicals and reagent used during the project 
work were either AR grade or LR. The reagents and 
chemicals used during experimental work are as Ethanol [AR 
grade]. 
2.3 Solvent selection: 
Both the drugs were found to be soluble in Ethanol 
AR grade after several trials of various solvents like Water, 
Methanol, NaOH, and Acetonitrile. There for ethanol is 
selected as a solvent system. The selection was made after 
assessing the solubility and stability of the drug in different 
solvents. 
2.4 Preparation of stock solution: [6-11] 
10mg of Aspirin and Omeprazole were separately 
weighed accurately and transferred into two 10 mL 
volumetric flasks. Ethanol was added into the volumetric 
flasks to dissolve the standards and finally volume was made 
upto the mark with ethanol to obtain standard solutions of 
Aspirin (1000μg/mL) and Omeprazole (1000μg/mL) 
respectively. 
2.5 Preparation of calibration curve of standard aspirin 
and omeprazole 
From standard stock solution of Aspirin 
(1000μg/mL), aliquots of 0.25mL, 0.50mL, 0.75mL, 1.00mL 
and 1.25mL were withdrawn and transferred to 10mL 
volumetric flasks. Volume was made upto the mark with 
ethanol to produce 25μg/mL, 50μg/mL, 75μg/mL, 100μg/mL 
and 125μg/mL of aspirin respectively. From the working 
standard solution of Omeprazole (100μg/mL), aliquots of 
0.3mL, 0.6mL, 0.9mL, 1.2mL and 1.5mL were transferred to 
10mL volumetric flasks and volume was made upto the mark 
with ethanol to produce 3μg/mL, 6μg/mL, 9μg/mL, 12μg/mL 
and 15μg/mL of omeprazole respectively. Mixed standard 
solutions of Aspirin and Omeprazole were prepared in ratio 
of 1:2.025 as present in the marketed formulation. 
2.5.1 Method I: Simultaneous equation method 
For the simultaneous equation method development, 
the wavelength absorbance maxima (λmax) of both drugs are 
required. The working standard solutions containing 
10μg/mL of Aspirin and 10μg/mL Omeprazole were scanned 
separately in the range of 200-600 nm for absorbance 
maxima (λmax) against ethanol as blank solution. Aspirin 
shows maximum absorption at 274 nm while Omeprazole at 
301 nm. From the overlain spectra of both the drugs 
wavelength selected for quantification were 274 nm for 
aspirin and 301 nm for omeprazole. The absorptivity 
coefficients of these two drugs were determined at selected 
wavelength and the concentrations of both drugs are 
calculated by using the equations (1) and (2). The absorption 
spectrum was obtained for aspirin, omeprazole and their 
overlay is shown in fig.4. 
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Fig. 3: Absorption spectrum of (a) Omeprazole and (b) Aspirin 
 
 
Fig. 4: Overlay spectrum of Aspirin and Omeprazole 
 
 
 
------------------------- (1) 
 
 
------------------------- (2) 
 
 
Where, Cx and Cy = the concentrations of Aspirin 
and Omeprazole respectively in gm/100 mL; A1 and A2 = the 
absorbance of mixture at λ1 (274 nm) and λ2 (301 nm) 
respectively ax1 and ax2 = the absorptivities of Aspirin at λ1 
(274 nm) and λ2 (301 nm) respectively ay1 and ay2 = the 
absorptivities of the Omeprazole at the λ1 (274 nm) and λ2 
(301 nm) respectively.  
2.5.2 Method II: Absorbance ratio method (Q-Analysis) 
Absorbance ratio method uses the ratio of 
absorbances at two selected wavelengths one which is an 
isoabsorptive point and other being the λ max of one of the 
two components. From the overlay spectra of two drugs it is 
evident that aspirin and omeprazole show an isoabsorptive 
point at 238.6 nm. The second wavelength used is 274 nm 
which is the λ max of aspirin. Six working standard solutions 
having concentration 25, 50, 75, 100, 125μg/mL for aspirin 
and 3, 6, 9, 12, 15μg/mL for omeprazole were prepared in 
ethanol and the absorbances at 238.6 nm (isoabsorptive point) 
and 274 nm (λ max of Aspirin) were measured and 
absorptivity coefficients were calculated using calibration 
curve. The concentration of two drugs in the mixture can be 
calculated using equations: 
 
        CX = [(QM – QY) / (QX -QY)] × A1/ax1 ................................ (3) 
        CY = (A1/ax1) – CX ................................................................ (4) 
 
Where, A1 and A2 are absorbances of mixture at 
274 nm and 238.6 nm, and ax1 and ay1 are absorptivities of 
aspirin and omeprazole at 238.6 nm, ax1 and ay1 are 
absorptivities of aspirin and omeprazole respectively at 
301nm and QM = A2 / A1, QX = ax2 / ax1 and QY = ay2 / 
ay1. 
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2.5.3 Method III: First derivative zero crossing point 
method: [13] 
Derivative spectroscopy on the basis of zero-
crossing measurements involves measurement of the absolute 
value of the total derivative spectrum at an abscissa value 
corresponding to the zero-crossing wavelength of the 
derivative spectra of individual components, which should be 
only a function of the concentration of other component. The 
absorption spectra of the solutions of aspirin and omeprazole 
were recorded in the range of 200 nm to 400 nm and were 
stored in the memory of the instrument and transformed to 
first derivative. Fig. 5 Show that at 274nm, aspirin shows 
zero crossing point and hence omeprazole can be determined 
while at 301nm, omeprazole shows zero crossing point and 
hence aspirin can be determined. 
 
Fig. 5 First derivative zero crossing point method 
 
 
2.5.4 Method IV: 
Area under curve 
For the simultaneous estimation using the area under 
curve method the working standard solution containing 
10μg/mL of aspirin and 10μg/mL omeprazole were scanned 
separately in the range of 200-600nm for absorbance maxima 
(λmax) against ethanol as blank solution. Aspirin shows 
maximum absorption at 274nm while Omeprazole at 301nm. 
The area under curve of the both the drugs were determined 
at the selected wavelengths in the range of 270nm - 276nm 
(Aspirin) and 300 nm - 305 nm (Omeprazole). The 
absorptivity coefficients of these two drugs were determined 
at selected area under curve and the concentrations of both 
drugs are calculated by using the equations (5) and (6). The 
area under curve spectrum was obtained for Aspirin and 
Omeprazole is shown in Fig.6. 
 
 
Fig. 6 AUC for Aspirin and Omeprazole 
 
CA = (XB2).(AUC M1) - (XB1) .(AUC M2) ---------------------- (5) 
 (XB2). (XA1) – (XB1). (XB1). (XB1) (XA2)  
CB = (XA2). (AUC M2) - (XA1). (AUC M1) ---------------------- (6) 
 (XB2). (XA1) – (XB1). (XB1). (XB1) (XA2)  
 
2.5.5 Preparation of calibration curve: [14-17] 
A stock solution of 100μg/ml of Aspirin and 
Omeprazole was prepared in ethanol. Appropriate aliquots of 
Aspirin and Omeprazole from stock solution further diluted 
with methanol to obtain 25, 50, 75, 100, 125μg/ml and 3, 6, 9, 
12, 15μg/ml concentration of Aspirin and Omeprazole 
respectively for both the methods. For the method-I, the 
absorbance of solution was measured at 274 nm and 301 nm 
and the calibration curves were plotted for these 
concentrations against absorbance value obtained at 
respective λmax and they are shown in Fig. 5 respectively and 
data are given in Table I. 
Wani   et al / International Journal of Advances in Pharmaceutics 2019; 08(01): e5306                                                                            e5306 
IJAP (2019) 08 (01)                                                     Page 5 of 7                                                             www.ssjournals.com    
 
Fig. 7 Calibration curves Aspirin 
 
Fig. 8 Calibration curves Omeprazole 
 
2.6 Validation of proposed method: 
2.6.1 Linearity: 
It is an analytical procedure is its ability (within a given range) to obtain test results which are directly proportional to 
the concentration (amount) of analyte in the sample. 
Table I: Linearity results of Aspirin and Omeprazole 
 
Sr. No 
Aspirin Omeprazole 
Conc. (µg/ml) Abs. at 274 Conc. (µg/ml) Abs. at 301 
1 25 0.1587 3 0.1828 
2 50 0.3491 6 0.3221 
3 75 0.5562 9 0.4841 
4 100 0.7149 12 0.6371 
5 125 0.9283 15 0.7923 
According to ICH guidelines Acceptance criteria- the regression co-efficient should NLT 0.99 
 
2.6.2 Precision: 
An analytical procedure expresses the closeness of agreement (degree of scatter) between a series of measurements 
obtained from multiple sampling of the same homogeneous sample under the prescribed conditions. 
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Table II: Precision results of Aspirin and Omeprazole in lowest concentration: 
Sr. 
No 
Aspirin Absorbance Absorptivity 
Omepr 
azole 
Absorbance Absorptivity 
 
Conc. 
(µg/ml) 
274nm 238.8nm 
274nm 
(ax1) 
238.8nm 
(ax2) 
Conc 
(µg/ml) 
301nm 238.8nm 
301nm 
(ay1) 
238.8nm 
(ay2) 
1 25 0.1588 0.5132 15.88 5.132 3 0.1874 0.2980 18.74 2.980 
2 25 0.1586 0.5158 15.86 5.158 3 0.1877 0.2981 18.77 2.981 
3 25 0.1588 0.5173 15.88 5.173 3 0.1872 0.2981 18.72 2.981 
4 25 0.1584 0.5182 15.84 5.182 3 0.1877 0.2983 18.77 2.983 
5 25 0.1581 0.5119 15.81 5.119 3 0.1876 0.2989 18.76 2.989 
   
Mean 15.85 5.152 
  
Mean 18.75 2.982 
SD 0.02 0.02 SD 0.02 0.003 
%RSD 0.18 0.51 %RSD 0.11 0.12 
 
Table III: Precision results of Aspirin and Omeprazole in highest concentration: 
Sr. No Aspirin Absorbance’s Absorptivity Omeprazole Absorbance’s Absorptivity 
 Conc. (µg/ml) 274nm 
238.8 n 
m 
274n 
m (ax1) 
238.8 
nm (ax2) 
Conc 
(µg/m l) 
301nm 
238.8n 
m 
301n 
m (ay1) 
238.8 
nm (ay2) 
1 125 0.9358 1.609 93.58 6.09 15 0.7892 1.5497 78.92 5.496 
2 125 0.9354 1.602 93.54 6.02 15 0.7885 1.5492 78.95 5.492 
3 125 0.9360 1.602 93.60 6.02 15 0.7897 1.5496 78.97 5.496 
4 125 0.9354 1.606 93.54 6.06 15 0.7894 1.5497 78.94 5.497 
5 125 0.9334 1.605 93.34 6.05 15 0.7898 1.5496 78.98 5.496 
   
Mean 93.52 6.046 
  
Mean 78.93 5.494 
SD 0.10 0.02 SD 0.051 0.003 
%RSD 0.11 0.47 %RSD 0.065 0.055 
According to ICH guidelines acceptance criteria for precision the %RSD should NMT 2 % 
 
2.6.3 Ruggedness and robustness:  
An analytical procedure is a measure of its capacity to remain unaffected by small, deliberate variations in method 
parameters and provides an indication of its reliability during normal usage. 
Ruggedness:  
Table IV: Ruggedness result 
Sr No Drug Conc. (µg/ml) Instrument Employed 
1  
Aspirin 
 Jasco V-630 Jasco V-730 
 ax1 ax2 ay1 ay2 
25 17.40 3.12 18.24 4.55 
  SD 0.094 0.027 0.089 0.031 
2 Omeprazole  ay1 ay2 ay1 ay2 
3 29.36 22.28 31.13 23.24 
SD 0.015 0.012 0.048 0.065 
 
Robustness: 
Table V: Robustness result 
 
Sr. No 
 
Drug 
Conc. 
(µg/ml) 
Temperature 
0°C -25°C Room 
temperature 
1 Aspirin  ax1 ax2 ay1 ay2 az1 az2 
25 17.40 3.12 18.24 4.55 0.1582 5.02 
SD 0.094 0.027 0.089 0.031 0.074 0.241 
2 Omeprazole ay1 ay2 ay1 ay2 az1 az2 
3 29.36 22.28 31.13 23.24 0.1845 64.23 
SD 0.015 0.012 0.048 0.065 0.093 0.079 
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3. Results and Discussion 
The proposed methods for simultaneous estimation 
of Aspirin and Omeprazole in combined dosage form were 
found to be accurate, simple and rapid. Since not a single 
method was reported for simultaneous analysis of the two 
drugs earlier, the developed methods can be used for routine 
analysis of two drugs in combined dosage forms. Absorbance 
ratio method uses the ratio of absorbances at two selected 
wavelengths, one which is an isoabsorptive point and other 
being the λ max of one of the two components. From the 
overlay spectra of two drugs, it is evident that aspirin and 
omeprazole show an isoabsorptive point at 238.6 nm. First 
derivative zero crossing point method shows that at 274 nm 
aspirin shows zero crossing point and hence omeprazole was 
determined. And while at 301nm omeprazole shows zero 
crossing point and hence aspirin was determined. Area under 
curve method involves formation and solving of simultaneous 
equation. Once the equations are formed, then only 
measurement of the area of sample solution at two 
wavelength ranges and simple calculations are required. It 
can be easily and conveniently adopted for routine quality 
control analysis. 
  
4. Conclusion 
The proposed methods for simultaneous estimation 
of Aspirin and Omeprazole in combined dosage form were 
found to be accurate, simple and rapid. Since not a single 
method was reported for simultaneous analysis of the two 
drugs earlier, the developed methods can be used for routine 
analysis of two drugs in combined dosage forms. This study 
is useful because these two drugs are commonly administered 
simultaneously. 
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